In 2009, a pentavalent vaccine containing diphtheria, tetanus, pertussis (whole-cell), Haemophilus influenza type b and hepatitis B (DTwP-Hib-HB) antigens was introduced in Argentina [8]. This evidence concerns the gene GSTM1 and diphtheria.